Seoul National University Bundang Hospital
Seoul 463-707
5 studies enrolling now · 20 studies all time
What they study most
Advanced Breast Cancer, Advanced Solid Tumor, Antibody-mediated Rejection, Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp, Atrial Fibrillation, Brain Diseases, Brain Neoplasms, Breast Cancer, Breast Diseases, Breast Neoplasms
Studies at this site
- Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer — Recruiting now
- Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer — Recruiting now
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors — Recruiting now
- A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors — Recruiting now
- Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress — Recruiting now
- Phase 2 Trial of HY209gel in Atopic Dermatitis Patients — Completed
- RegoNivo vs Standard of Care Chemotherapy in AGOC — Completed
- Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
- A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) — Running, not enrolling
- First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer — Running, not enrolling
- An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer. — Completed
- A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer — Stopped early
- Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
- Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer — Completed
- First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer — Running, not enrolling
- The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis — Stopped early
- Impact of Fever Prevention in Brain Injured Patients — Stopped early
- LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices — Completed
- A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer — Status unconfirmed
- Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection — Stopped early